Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.
Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma. Int J Clin Exp Pathol. 2010 Jul 05; 3(6):608-17.
View in:
PubMed
subject areas
3-Hydroxysteroid Dehydrogenases
3-Hydroxysteroid Dehydrogenases
Adenocarcinoma
Adenocarcinoma
Aldo-Keto Reductase Family 1 Member C3
Aldo-Keto Reductase Family 1 Member C3
Biomarkers, Tumor
Biomarkers, Tumor
Endometrial Hyperplasia
Endometrial Hyperplasia
Endometrial Neoplasms
Endometrial Neoplasms
Female
Female
Gene Expression
Gene Expression
Gene Expression Profiling
Gene Expression Profiling
Humans
Humans
Hydroxyprostaglandin Dehydrogenases
Hydroxyprostaglandin Dehydrogenases
Immunohistochemistry
Immunohistochemistry
authors with profiles
Kar-Ming Fung